Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 08:01 am Unchanged | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | Hawkes Bay Master Investors (Cayman) L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-03 2:36 pm Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | FRANKLIN RESOURCES INC BEN | 251,277 5.800% | 251,277 (New Position) | Filing History |
| 2022-01-31 9:02 pm Unchanged | 2021-12-31 | 13G | Chimerix, Inc. CMRX | Opaleye Management Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-10-15 4:49 pm Purchase | 2021-10-05 | 13G | Gemini Therapeutics, Inc. GMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 223,284 5.200% | 223,284 (New Position) | Filing History |
| 2021-02-22 3:47 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | ORBIMED ADVISORS LLC | 582,622 12.900% | 582,622 (New Position) | Filing History |
| 2021-02-16 5:28 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | Lightstone Ventures L.P. | 483,611 10.700% | 483,611 (New Position) | Filing History |
| 2021-02-16 5:25 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | Atlas Venture Fund X, L.P. | 401,505 8.900% | 401,505 (New Position) | Filing History |
| 2021-02-16 11:21 am Purchase | 2020-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | Alyeska Investment Group, L.P. | 84,605 6.800% | 84,605 (New Position) | Filing History |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | FS DEV CORP COM FSDC | Opaleye Management Inc. | 704,400 5.630% | 36,000 (+5.39%) | Filing History |
| 2021-02-12 4:39 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | FS Development Holdings LLC | 487,025 10.750% | 487,025 (New Position) | Filing History |
| 2021-02-04 11:19 am Purchase | 2020-12-31 | 13G | FS DEV CORP COM FSDC | Wellington Management Group LLP | 990,000 7.910% | 990,000 (New Position) | Filing History |